StocksCellectis SACLLS

CLLS

Cellectis SA

14.84 -0.25 (-1.66%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
14.84
B
14.91

Cellectis SA

Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. It is a clinical-stage biopharmaceutical company, focused on developing and marketing genetically-edited T-cell- based immuno-oncology products for treating leukemia patients. The company also develops innovative plant-based products... Show More
Last Month
10,747
Followers
0.49%
Investors
100% Of them have BUY positions.
An Increase of 0% from last trading Day

Related Markets

Crest Nicholson Holdings plc
CRST.L
5.39 (1.30%)
S
420.42
B
421.98
A O Smith Corp
AOS
-0.76 (-1.14%)
S
65.96
B
66.11
Persimmon
PSN.L
21.98 (0.73%)
S
3025.27
B
3031.73
Masco Corp
MAS
-1.26 (-2.13%)
S
57.80
B
57.94
Securitas AB ser. B
SECU-B.ST
-0.72 (-0.56%)
S
127.93
B
128.27
View More

Investors

View More
Top
Kevin Fyffe
United Kingdom
Hello all, Ok, I'll admit there have been a lot of tables posted today, with the monthly review and eToro adding new assets to the website. Here are the final tables for this week, it's the usual weekly ones. The Top 10 charts based on the analysts predictions in the 'Research' Tab. 4... Show More
Like CommentShare
Show more comments2 of 3
null
.
Kevin Fyffe
United Kingdom
Hello all, Ok, I'll admit there have been a lot of tables posted today, with the monthly review and eToro adding new assets to the website. Her